American Society of Hematology, Blood, 3(129), p. 371-382, 2017
DOI: 10.1182/blood-2016-09-739003
Full text: Download
Key PointsCCL2 is a KIT D816V–induced cytokine targeting microenvironmental cells in mastocytosis in vitro and in vivo. Serum levels of CCL2 in patients with mastocytosis correlate with advanced disease and poor survival.